153
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Blood pressure 2 years after a chronic disease management intervention study

, , , , , , , , , & show all
Pages 50-60 | Received 11 Jun 2009, Accepted 11 Nov 2009, Published online: 18 Mar 2012

References

  • Kaler SN, Ralph-Campbell K, Pohar S, King M, Laboucan CR, Toth EL. High rates of the metabolic syndrome in a First Nations Community in western Canada: prevalence and determinants in adults and children. Int J Circumpolar Health 2006 Dec;65 (5): 389–402.
  • Bakris GL, Williams M, Dworkin L, Elliott WI, Epstein M, Toto R, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000 Sep; 36 (3): 646–661.
  • Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 2002 Nov; 13(11):2776–2782.
  • Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group. [see comments]. BMJ 1998 Sep 12;317 (7160): 720–726.
  • Baker PR, Hoy WE, Thomas RE. Cost-effectiveness analysis of a kidney and cardiovascular disease treatment program in an Australian Aboriginal population. Adv Chronic Kidney Dis 2005 Jan; 12 (1): 22–31.
  • Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2—therapy. Can J Cardiol 2009 May; 25 (5): 287–298.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 Dec; 42 (6): 1206–1252.
  • Hemmelgarn BR, McAlister FA, Grover S, Myers MG, McKay DW, Bolli P, et al. The 2006 Canadian Hypera-tension Education Program recommendations for the management of hypertension: Part I— Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2006 May 15; 22 (7): 573–581.
  • McFarlane PA, Holden R, Harris SB, Tobe SW. Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Nephropathy. Canadian Journal of Diabetes 2003; 27(Suppl 2):566–571.
  • Joffres MR, Hamet P, MacLean DR, L’Italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001 Nov; 14 (11 Pt 1):1099–1105.
  • Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 May 1; 27 (5): 1047–1053.
  • Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care 2006 Sep;29 (9): 2114–2116.
  • Lipscombe LL, hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet 2007; 369 (9563): 750–756.
  • Pedersen ML. Management of type 2 diabetes mellitus in Greenland, 2008: examining the quality and organization of diabetes care. Int J Circumpolar Health 2009 Apr; 68 (2): 123–132.
  • Ménard J, Payette H, Baillargeon JP, Maheux P, Lepage S, Tessier D, et al. Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial. CMAJ 2005 Dec 6; 173 (12): 1457–1466.
  • Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008 Oct 9; 359 (15): 1565–1576.
  • Ruzicka M, Leenen FH. Moving beyond guidelines: are report cards the answer to high rates of uncontrolled hypertension? Curr Hypertens Rep 2006 Aug;8 (4): 324–329.
  • Tobe SW, Pylypchuk G, Wentworth J, Kiss A, Szalai JP, Perkins N, et al. Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial. CMAJ 2006 Apr 25; 174 (9): 1267–1271.
  • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 2003;27(Suppl 2):S58–S65.
  • Harris SB, Lank CN. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors. Can Fam Physician 2004 Mar; 50: 425–433.
  • Myers MG, Valdivieso MA. Use of an automated blood pressure recording device, the BpTRU, to reduce the “white coat effect” in routine practice. Am J Hypertens 2003 Jun; 16 (6): 494–497.
  • Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991 [see comments]. Hypertension 1995 Mar;25 (3): 305–313.
  • Reed HL, Bernard E. Reductions in diabetic cardiovascular risk by community primary care providers. Int J Circumpolar Health 2005 Feb; 64 (1): 26–37.
  • Pylypchuk G, Vincent L, Wentworth J, Kiss A, Perkins N, Hartman S, et al. Diabetes risk evaluation and microalbuminuria (DREAM) studies: ten years of participatory research with a first nation’s home and community model for type 2 diabetes care in Northern Saskatchewan. Int J Circumpolar Health 2008 Jun; 67 (2–3): 190–202.
  • Wilson K, Young TK. An overview of Aboriginal health research in the social sciences: current trends and future directions. Int J Circumpolar Health 2008 Jun; 67 (2–3): 179–189.
  • Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002 Oct 9; 288 (14): 1775–1779.
  • Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 2009 Apr; 53 (4): 646–653.
  • Hoy WE, Wang Z, Baker PR, Kelly AM. Secondary prevention of renal and cardiovascular disease: results of a renal and cardiovascular treatment program in an Australian aboriginal community. J Am Soc Nephrol 2003 Jul; 14(7 Suppl 2):5178–5185.
  • Centers for Disease Control and Prevention (CDC). Racial differences in trends of end-stage renal disease, by primary diagnosis - United States, 1994–2004. MMWR Morb Mortal Wkly Rep 2007 Mar 23;56 (11): 253–256.